MAA
Matrix Asset Advisors’s EyePoint Pharmaceuticals EYPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-39,500
| Closed | -$20K | – | 89 |
|
2020
Q3 | $20K | Hold |
39,500
| – | – | ﹤0.01% | 78 |
|
2020
Q2 | $30K | Buy |
39,500
+13,000
| +49% | +$9.87K | 0.01% | 75 |
|
2020
Q1 | $27K | Hold |
26,500
| – | – | 0.01% | 69 |
|
2019
Q4 | $41K | Hold |
26,500
| – | – | 0.01% | 75 |
|
2019
Q3 | $48K | Hold |
26,500
| – | – | 0.01% | 73 |
|
2019
Q2 | $43K | Hold |
26,500
| – | – | 0.01% | 66 |
|
2019
Q1 | $47K | Sell |
26,500
-2,000
| -7% | -$3.55K | 0.01% | 66 |
|
2018
Q4 | $54K | Hold |
28,500
| – | – | 0.01% | 68 |
|
2018
Q3 | $102K | Hold |
28,500
| – | – | 0.02% | 63 |
|
2018
Q2 | $59K | Buy |
+28,500
| New | +$59K | 0.01% | 64 |
|
2018
Q1 | – | Sell |
-28,500
| Closed | -$31K | – | 66 |
|
2017
Q4 | $31K | Sell |
28,500
-9,000
| -24% | -$9.79K | ﹤0.01% | 66 |
|
2017
Q3 | $45K | Buy |
37,500
+11,000
| +42% | +$13.2K | 0.01% | 65 |
|
2017
Q2 | $45K | Hold |
26,500
| – | – | 0.01% | 65 |
|
2017
Q1 | $46K | Hold |
26,500
| – | – | 0.01% | 64 |
|
2016
Q4 | $45K | Sell |
26,500
-4,000
| -13% | -$6.79K | 0.01% | 72 |
|
2016
Q3 | $92K | Hold |
30,500
| – | – | 0.02% | 74 |
|
2016
Q2 | $86K | Hold |
30,500
| – | – | 0.02% | 70 |
|
2016
Q1 | $82K | Buy |
30,500
+500
| +2% | +$1.34K | 0.02% | 70 |
|
2015
Q4 | $145K | Hold |
30,000
| – | – | 0.03% | 74 |
|
2015
Q3 | $110K | Hold |
30,000
| – | – | 0.02% | 66 |
|
2015
Q2 | $113K | Hold |
30,000
| – | – | 0.01% | 72 |
|
2015
Q1 | $119K | Hold |
30,000
| – | – | 0.01% | 74 |
|
2014
Q4 | $123K | Hold |
30,000
| – | – | 0.01% | 74 |
|
2014
Q3 | $133K | Buy |
30,000
+6,000
| +25% | +$26.6K | 0.02% | 70 |
|
2014
Q2 | $104K | Hold |
24,000
| – | – | 0.01% | 72 |
|
2014
Q1 | $98K | Buy |
24,000
+4,000
| +20% | +$16.3K | 0.01% | 71 |
|
2013
Q4 | $79K | Buy |
20,000
+5,000
| +33% | +$19.8K | 0.01% | 69 |
|
2013
Q3 | $62K | Hold |
15,000
| – | – | 0.01% | 67 |
|
2013
Q2 | $58K | Buy |
+15,000
| New | +$58K | 0.01% | 67 |
|